Aster Hospital Mankhool Introduces Cutting-Edge Robotic Orthopedic Centre
By Editor_wr On Apr 15, 2025
Aster Hospital Mankhool, ranked No. 4 on Newsweek's World's Best Hospitals in the UAE list for 2025, has launched its state-of-the-art Robotic Surgery Centre, marking a significant advancement in orthopedic care with the introduction of the ROSA® Robotic Knee Joint Replacement System. This cutting-edge robotic surgical assistant works alongside surgeons from pre-surgery planning through to the procedure itself, enhancing accuracy and reducing the risk of surgical errors in bone preparation and implant placement. As the first robotic surgery facility within Aster Hospitals in the UAE, this milestone underscores the hospital's commitment to providing world-class, technology-driven healthcare solutions.
The Robotic Surgery Centre was officially inaugurated by Olympic boxing legend and former Rajya Sabha Member, Mary Kom, who lauded the hospital's commitment to innovation and patient-centric advancements in healthcare.
Studies indicate that the global knee replacement market is projected to reach USD 17.35 billion by 20341, driven by an increasing aging population, osteoarthritis and rising patient demand for effective, long-lasting treatments. Robotic-assisted knee replacement surgery addresses the challenges of traditional procedures by offering greater precision, reducing recovery time, and improving implant longevity.
ROSA® assists surgeons by generating a 3D model of the patient's knee using preoperative CT scans (rather than X-rays), enabling a highly personalized and accurate surgical approach. By providing real-time data and intraoperative feedback, the system ensures optimal implant positioning, reduces surgical errors, and enhances joint function. The robotic assistance allows for customized treatment plans tailored to each patient's unique anatomy, significantly improving overall results.
Commenting on the launch, Dr. Malathi Arshanapalai, Group Chief Medical Officer and Group Chief Quality Officer, Aster DM Healthcare, said 'At Aster, we are committed to continuously innovating and adopting advanced technologies that improve patient outcomes. The introduction of the robotic knee joint replacement system at Aster Hospital Mankhool is a testament to our vision of making high-quality, technology-driven healthcare accessible to our patients. With robotic-assisted surgery, we are bringing the future of orthopedic care to the region, ensuring more precision, faster recovery, and better overall experiences for patients undergoing knee replacement procedures.'
The adoption of robotic-assisted knee replacement surgery at Aster Hospital Mankhool includes both knee and hip replacement surgeries, bringing multiple advantages over traditional procedures. Patients benefit from smaller incisions, minimal tissue disruption, and a reduced risk of complications, such as infections and nerve damage. The advanced technology enhances joint stability, ensuring proper alignment and lowering the risk of misalignment-related issues. Moreover, the precision of robotic assistance leads to improved implant longevity, potentially extending the lifespan of the prosthetic knee.
Dr. Ranjith Narayan, Specialist Orthopaedics, Aster Hospital Mankhool, added, 'The introduction of the ROSA® Robotic Knee Joint Replacement System at Aster Hospital Mankhool is a game-changer in orthopedic care. This advanced robotic system enhances surgical precision by utilizing real-time data and 3D modeling, allowing for a highly personalized approach tailored to each patient's unique anatomy. By ensuring optimal implant positioning and minimizing surgical errors, the technology significantly improves joint function, reduces recovery time, and enhances overall patient outcomes. With robotic-assisted surgery, we are not only elevating the standard of knee replacement procedures but also providing our patients with a safer, more effective, and long-lasting treatment solution.'
With reduced postoperative pain and a faster rehabilitation process, patients can expect shorter hospital stays and quicker recovery times. The minimally invasive nature of robotic-assisted surgery also reduces blood loss and promotes faster healing, contributing to an improved quality of life for individuals undergoing both knee and hip replacement surgeries. This technology is particularly beneficial for patients with severe arthritis or complex anatomical structures, offering them an advanced surgical solution for enhanced mobility and long-term joint health.
With this introduction, Aster Hospital Mankhool reaffirms its commitment to integrating innovation and excellence into patient care. This launch represents a transformative step forward in orthopedic treatment, ensuring that patients receive the most precise, effective, and minimally invasive surgical interventions available. Aster Hospital Mankhool Introduces Cutting-Edge Robotic Orthopedic Centre
Comments are closed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Filipino Times
2 days ago
- Filipino Times
Over 200 Filipino health workers to depart for Japan
A total of 218 Filipino health workers will soon leave for Japan, following a send-off ceremony organized by the Department of Migrant Workers (DMW). This 17th batch includes 19 nurses and 199 careworkers, scheduled to depart on June 10 and 11, after completing the required training under the Philippines-Japan Economic Partnership Agreement (PJEPA). In his speech, Migrant Workers Secretary Hans Leo Cacdac emphasized President Ferdinand R. Marcos Jr.'s full support for Filipino workers going abroad and lauded their dedication, likening them to Olympic gold medalists. 'It's been proven time and again. It's you guys who are number one. You are the Olympic gold medalists every single day. Nobody can do what you can do.' PJEPA, the Philippines' first bilateral free trade agreement signed in 2006 and implemented in 2009, also covers the deployment of qualified Filipino health professionals to Japan, sending a total of 655 nurses and 3,760 careworkers since it began. Japanese officials also expressed their strong support, with Japan Foundation Manila Director Ben Suzuki emphasizing the sacrifices made by Filipino workers and their contribution to Japan. 'For Filipino people, working abroad means a sacrifice rooted in love for their family and dignity of life, more than earning enough income. The dedication and cultural values that can help enrich today's Japanese society,' Suzuki said.
Al Etihad
4 days ago
- Al Etihad
M42, AstraZeneca, SOPHiA GENETICS to transform cancer diagnosis, care
3 June 2025 14:30 ABU DHABI (ALETIHAD)M42, a global health leader powered by technology, announced a strategic collaboration with AstraZeneca and SOPHiA GENETICS to bring cutting-edge liquid biopsy testing to the UAE, aimed at advancing cancer diagnosis, informing treatment decisions, and enabling faster, accurate biomarker testing across a broad range of part of the collaboration, M42 will integrate SOPHiA GENETICS' MSK-ACCESS®, powered with SOPHiA DDM™ technology, into its testing infrastructure, enabling non-invasive genomic profiling of cancers through a simple blood approach does not replace but rather complements routine cancer screenings, and is designed for patients who are unable to undergo a solid tumor biopsy, enabling them to be matched with a precision therapy tailored to their specific cancer the next 12 months, the partnership will enable liquid biopsy testing access across select leading hospitals across the UAE, providing patients with faster, less invasive biomarker insights compared to traditional tissue biopsies, while also strengthening testing infrastructure and capabilities for a wide range of cancers in the new testing programme will initially target lung, ovarian, breast, colorectal, and pancreatic cancers, among others, addressing some of the most critical cancer burdens in the studies are set to commence shortly at Cleveland Clinic Abu Dhabi, marking a key milestone toward the full clinical launch planned for the latter part of Q2 El-khani, Senior Vice President, Operations, Integrated Health Solutions at M42, said, 'This collaboration reflects our vision of democratising health by making advanced diagnostics accessible to more patients, supporting not just early diagnosis but also real-time treatment monitoring and cost-effective, precise, predictive, and personalised care.'Sameh El Fangary, Cluster President GCC of AstraZeneca, stated, "Our work, and our collaborations with partners across industry, are driving towards better treatments for patients as well as a more sustainable future for healthcare systems. Through our latest partnerships, we are committed to transforming cancer care for millions in the region by advancing early diagnosis and optimising patient pathways from detection to therapy.' Ross Muken, President of SOPHiA GENETICS, said, "Expanding access to advanced testing technologies is central to our mission at SOPHiA GENETICS. Partnering with M42 and AstraZeneca in the UAE allows us to equip healthcare providers with the tools they need to personalise care, monitor disease in real-time, and ultimately improve outcomes for patients across the region." Source: Aletihad - Abu Dhabi
Web Release
5 days ago
- Web Release
PureHealth drives insurance business growth with Daman's entry into Property and Casualty insurance market
PureHealth, the largest hospital and health insurance group in the Middle East, today announced the strategic expansion of its insurance arm, Daman, marking its transformation from a health-focused provider into a comprehensive, multi-line insurer with entry into the high-growth Property and Casualty (P&C) segment. As part of this evolution, Daman will adopt a new legal name: The National Insurance Company – Daman, reflecting its broadened scope and strengthened position within the UAE's dynamic insurance landscape. The transition reflects Daman's broader mission to meet the evolving protection needs of individuals and businesses across the emirates by offering them a broader suite of insurance services. As the insurance arm of PureHealth and the UAE's leading health insurer, Daman's expansion into the P&C segment supports its vision to become a comprehensive insurance provider and aligns with the group's commitment to deliver holistic care and coverage throughout all stages of life. Shaista Asif, Group Chief Executive Officer of PureHealth, stated: 'Daman's evolution reflects PureHealth's broader strategy to create a fully integrated healthcare and insurance platform that drives better customer service and long-term value creation. Expanding into the Property and Casualty segment enhances portfolio diversification, supports risk management across sectors, and reinforces our commitment to shaping a future-ready ecosystem aligned with the UAE's economic and social development priorities.' H.E. Khaled Binshaiban Almheiri, Chairman of The National Insurance Company – Daman, commented: 'For nearly two decades, Daman has set the benchmark for health insurance in the UAE. This evolution marks a pivotal chapter – expanding our focus to offer a broader range of insurance solutions while maintaining the same rigour, trust and customer-first mindset our members know and value. By protecting individuals, businesses and assets, we are proud to play a central role in supporting the UAE's vision for sustainable wellbeing and long-term economic resilience.' Daman currently provides health coverage to more than three million members across a network of over 3,000 healthcare providers in the UAE. Backed by a resilient operational backbone, Daman brings together AI-powered underwriting, industry-leading efficiency in claim settlement, and a multilingual service delivery infrastructure to seamlessly support its expansion into new insurance verticals, without compromising its longstanding reputation for excellence. As per the Central Bank of the UAE (CBUAE), the total number of written insurance policies for all types of insurance within the UAE increased to 14.6 million policies year-on-year in 2023, compared to 8.4 million policies in 2022, due to a higher number of property and liability insurance policies. The UAE's P&C insurance market is poised for further accelerated growth, which is projected to reach nearly USD 16.8 billion by 2031, according to Verified Market Research. In response to this growing demand, the company will continue to operate under the well-established Daman brand, introducing new P&C products in phases while ensuring uninterrupted service for existing members. Daman was named the best perceived health insurance brand in the UAE, according to the UAE Healthcare 2024 report from Brand Finance – a recognition that reflects its commitment to excellence and mission to cultivate a healthier community. This strategic growth plan reinforces PureHealth's broader vision to advance the science of longevity and deliver the promise of holistic care, from prevention to protection, through a connected health and insurance ecosystem.
